Literature DB >> 23544843

Zona pellucida birefringence and meiotic spindle visualisation of human oocytes are not influenced by IVM technology.

Marjan Omidi1, Mohammad Ali Khalili1, Sareh Ashourzadeh1, Marzieh Rahimipour1.   

Abstract

The aim of the present study was to investigate the relationship between the presence of the meiotic spindle and zona pellucida (ZP) birefringence with morphology of in vivo- and in vitro-matured human oocytes. Germinal vesicles (n=47) and MI (n=38) oocytes obtained from stimulated ovaries of patients undergoing intracytoplasmic sperm injection (ICSI) underwent IVM. Using a PolScope (OCTAX PolarAID; Octax, Herbon, Germany), the presence of spindles and ZP birefringence was assessed in both in vivo-matured (n=56) and IVM (n=56) oocytes. In addition, the morphology of each matured oocyte was evaluated microscopically. There were insignificant differences for ZP birefringence and meiotic spindle between the in vivo-matured and IVM MII oocytes. Subanalysis revealed that the rates of morphologically abnormal oocytes did not differ significantly between the two groups, except in the case of irregular shape (P=0.001), refractile body (P=0.001) and fragmented polar body (P=0.03), which were higher in IVM oocytes. In the case of in vivo-matured oocytes, a significantly higher percentage of oocytes with intracytoplasmic and both intra- and extracytoplasmic abnormalities have a low birefringent ZP (P=0.007 and P=0.02, respectively). There was no relationship between morphological abnormalities and spindle detection. The findings suggest that clinical IVM is a safe technology that maintains the high maturation rate and integrity of oocytes. In addition, the use of the non-invasive PolScope is recommended for the detection of oocytes most suitable for ICSI.

Entities:  

Mesh:

Year:  2014        PMID: 23544843     DOI: 10.1071/RD13001

Source DB:  PubMed          Journal:  Reprod Fertil Dev        ISSN: 1031-3613            Impact factor:   2.311


  8 in total

1.  High efficiency of homemade culture medium supplemented with GDF9-β in human oocytes for rescue in vitro maturation.

Authors:  Mehdi Mohsenzadeh; Mohammad Ali Khalili; Fatemeh Anbari; Mahboubeh Vatanparast
Journal:  Clin Exp Reprod Med       Date:  2022-05-27

2.  Use of both cumulus cells' transcriptomic markers and zona pellucida birefringence to select developmentally competent oocytes in human assisted reproductive technologies.

Authors:  Mourad Assidi; Markus Montag; Marc-André Sirard
Journal:  BMC Genomics       Date:  2015-01-15       Impact factor: 3.969

3.  Does women's age influence zona pellucida birefringence of metaphase ΙΙ oocytes in in-vitro maturation program?

Authors:  Marjan Omidi; Mohammad Ali Khalili; Hossein Nahangi; Sareh Ashourzadeh; Marzieh Rahimipour
Journal:  Iran J Reprod Med       Date:  2013-10

4.  Vitrification has detrimental effects on maturation, viability, and subcellular quality of oocytes post IVM in cancerous women: An experimental study.

Authors:  Mehdi Mohsenzadeh; Nasim Tabibnejad; Mahboubeh Vatanparast; Fatemeh Anbari; Mohammad Ali Khalili; Mojgan Karimi-Zarchi
Journal:  Int J Reprod Biomed       Date:  2019-05-05

5.  Efficacy of the in vitro splitting of human preimplantation embryos from ART programs

Authors:  Marjan Omidi; Mohammad Ali Khalili; Azam Agha- Rahimi; Stefania Nottola; Fatemeh Anbari; Azita Faramarzi; Maria Grazia Palmerini
Journal:  Turk J Med Sci       Date:  2021-02-26       Impact factor: 0.973

6.  Analysis of maturation dynamics and developmental competence of in vitro matured oocytes under time-lapse monitoring.

Authors:  Qiyu Yang; Lixia Zhu; Meng Wang; Bo Huang; Zhou Li; Juan Hu; Qingsong Xi; Jing Liu; Lei Jin
Journal:  Reprod Biol Endocrinol       Date:  2021-12-10       Impact factor: 5.211

7.  Developmental competence of immature oocytes aspirated from antral follicles in patients with gynecological diseases.

Authors:  Fereshteh Safian; Mohammad Ali Khalili; Mojgan Karimi-Zarchi; Mehdi Mohsenzadeh; Sareh Ashourzadeh; Marjan Omidi
Journal:  Iran J Reprod Med       Date:  2015-08

8.  Clinical outcomes of MII oocytes with refractile bodies in patients undergoing ICSI and single frozen embryo transfer.

Authors:  Hiromi Takahashi; Junko Otsuki; Michio Yamamoto; Hiroe Saito; Rei Hirata; Toshihiro Habara; Nobuyoshi Hayashi
Journal:  Reprod Med Biol       Date:  2019-11-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.